A Phase 1 Study of KHK4083: A Single‐Blind, Randomized, Placebo‐Controlled Single‐Ascending‐Dose Study in Healthy Adults and an Open‐Label Multiple‐Dose Study in Patients With Ulcerative Colitis.
Saved in:
| Title: | A Phase 1 Study of KHK4083: A Single‐Blind, Randomized, Placebo‐Controlled Single‐Ascending‐Dose Study in Healthy Adults and an Open‐Label Multiple‐Dose Study in Patients With Ulcerative Colitis. |
|---|---|
| Authors: | Furihata, Kenichi1 (AUTHOR) furihata@p1-clinic.or.jp, Ishiguro, Yoh2 (AUTHOR), Yoshimura, Naoki3 (AUTHOR), Ito, Hiroaki4 (AUTHOR), Katsushima, Shinji5 (AUTHOR), Kaneko, Etsuji6 (AUTHOR), Shimabe, Munetake6 (AUTHOR), Mukai, Mayumi6 (AUTHOR), Watanabe, Risa6 (AUTHOR), Morishige, Takuya6 (AUTHOR) |
| Source: | Clinical Pharmacology in Drug Development. Aug2021, Vol. 10 Issue 8, p870-883. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2160763X |
|---|---|
| DOI: | 10.1002/cpdd.918 |
